Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Jessica Lin

Massachusetts General Hospital

United States

Research Interests

Explore related searches

Professors in United States

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (8)

Arthi Sridhar

Assistant Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

Xingping Qin

Harvard University

UNITED STATES

View details

Bruno Bockorny

Beth Israel Deaconess Medical Center

UNITED STATES

View details

Ferran Fece de la Cruz

Group Leader

Rigshospitalet

DENMARK

View details

Christian Johnson

Assistant Professor

University of South Carolina

UNITED STATES

View details

tariq abuali

City Of Hope National Medical Center

UNITED STATES

View details

Benjamin Solomon

Professor

University of Melbourne

AUSTRALIA

View details

Amin Nassar

Yale University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jessica Lin

Research Interests

Explore related searches

Articles (20)

First Results of Migoprotafib, a Potent and Highly Selective Src Homology-2 Domain–Containing Phosphatase 2 Inhibitor in Patients with Advanced Solid Tumors

Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC

LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers

GUK1 activation is a metabolic liability in lung cancer.

A Podcast Discussion on the Intracranial Efficacy of Antibody-Drug Conjugates in Patients with <i>EGFR</i>-Mutated NSCLC with Brain Metastases

A plain language summary of two trials for larotrectinib in people with TRK fusion-positive lung cancer to learn how well the drug works and how safe it is

Alectinib combined with cobimetinib in ALK-Rearranged lung Cancer: A phase IB study

Evolution of first versus next-line targeted therapies for metastatic non-small cell lung cancer

Final Overall Survival and Long-Term Safety of Lorlatinib in Patients With ALK-Positive NSCLC From the Pivotal Phase 2 Study: A Brief Report

Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS<SUP>G12C</SUP> inhibitors

Lung Carcinoid Tumors With Potentially Actionable Genomic Alterations and Responses to Targeted Therapies

Phase 2 Trial of Consolidative Stereotactic Body Radiation Therapy in Patients With Metastatic Oncogene-driven Non-small Cell Lung Carcinoma Treated With Tyrosine Kinase Inhibitors

Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer (vol 195, 107919, 2024)

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Advances and future directions in ROS1 fusion-positive lung cancer

Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK -positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919]

Current opportunities and challenges in ALK-positive lung cancer

Efficacy and Safety of Dose-Escalated Alectinib in Patients With Metastatic ALK-Positive NSCLC and Central Nervous System Relapse on Standard-Dose Alectinib

Frequency of clinical acquired RAS-MAPK pathway resistance alterations in patients treated with KRASG12C inhibitors: An individual patient meta-analysis

LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers

Collaborators (8)

Arthi Sridhar

Xingping Qin

Bruno Bockorny

Ferran Fece de la Cruz

Christian Johnson

tariq abuali

Benjamin Solomon

Amin Nassar

Make your next move.